Tamara Isakova

  • 7942 Citations
20052023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Isakova is a clinical nephrologist with experience in patient-oriented and epidemiological research of disordered mineral metabolism in chronic kidney disease. Dr. Isakova provides clinical care for patients with chronic kidney disease and bone and mineral metabolism disorders and for patients with kidney stones.

Certifications and Licenses

Internal Medicine
Nephrology

Training Experience

2004Internship, Massachusetts General Hospital
2006Residency, Massachusetts General Hospital
2010Fellowship, Massachusetts General Hospital and Brigham and Women’s Hospital

Education/Academic qualification

MMSc, Harvard Medical School

… → 2009

MD, SUNY-Downstate Medical Center

… → 2003

Keywords

  • Clinical Research
  • Clinical Trial Methodology
  • Renal Diseases

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Chronic Renal Insufficiency Medicine & Life Sciences
Phosphates Medicine & Life Sciences
Parathyroid Hormone Medicine & Life Sciences
Phosphorus Medicine & Life Sciences
Minerals Medicine & Life Sciences
Chronic Kidney Failure Medicine & Life Sciences
Hyperphosphatemia Medicine & Life Sciences
Mortality Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2013 2023

Research Output 2005 2019

Association of Fitness With Racial Differences in Chronic Kidney Disease

Paluch, A. E., Pool, L. R., Isakova, T., Lewis, C. E., Mehta, R. C., Schreiner, P. J., Sidney, S., Wolf, M. & Carnethon, M. R., Jul 1 2019, In : American Journal of Preventive Medicine. 57, 1, p. 68-76 9 p.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Glomerular Filtration Rate
Incidence
Blood Pressure
Exercise Test

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

Frazier, R. S., Mehta, R. C., Cai, X., Lee, J., Napoli, S., Craven, T., Tuazon, J. A., Safdi, A. W., Scialla, J., Susztak, K. & Isakova, T., Jan 1 2019, In : Kidney International Reports. 4, 1, p. 94-102 9 p.

Research output: Contribution to journalArticle

Fenofibrate
Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Glomerular Filtration Rate
Incidence

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., Feng, J. Q., Isakova, T., Wolf, M., David, N. V. & Martin, A., Dec 1 2019, In : Bone Research. 7, 1, 12.

Research output: Contribution to journalArticle

Open Access
Osteocytes
Left Ventricular Hypertrophy
Dentin
Chronic Renal Insufficiency
Proteins

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

Ix, J. H., Isakova, T., Larive, B., Raphael, K. L., Raj, D. S., Cheung, A. K., Sprague, S. M., Fried, L. F., Gassman, J. J., Middleton, J. P., Flessner, M. F., Block, G. A. & Wolf, M., Jun 1 2019, In : Journal of the American Society of Nephrology : JASN. 30, 6, p. 1096-1108 13 p.

Research output: Contribution to journalArticle

Niacinamide
Phosphates
Serum
Placebos
lanthanum carbonate
1 Citation (Scopus)

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study

Akhabue, E., Vu, T. H. T., Vaidya, A., Michos, E. D., De Boer, I. H., Kestenbaum, B., Allison, M., Szklo, M., Ouyang, P., Yancy, C. W., Wolf, M., Isakova, T. & Carnethon, M. R., Jan 1 2019, In : American Journal of Hypertension. 32, 1, p. 18-25 8 p.

Research output: Contribution to journalArticle

Renin-Angiotensin System
Atherosclerosis
Heart Failure
Hypertension
Angiotensin Receptor Antagonists